0000950170-23-069190.txt : 20231211 0000950170-23-069190.hdr.sgml : 20231211 20231211064508 ACCESSION NUMBER: 0000950170-23-069190 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231207 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231211 DATE AS OF CHANGE: 20231211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VAPOTHERM INC CENTRAL INDEX KEY: 0001253176 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 462259298 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38740 FILM NUMBER: 231476885 BUSINESS ADDRESS: STREET 1: 100 DOMAIN DRIVE CITY: EXETER STATE: NH ZIP: 03833 BUSINESS PHONE: 603-658-0411 MAIL ADDRESS: STREET 1: 100 DOMAIN DRIVE CITY: EXETER STATE: NH ZIP: 03833 8-K 1 vapo-20231207.htm 8-K 8-K
0001253176false00012531762023-12-072023-12-07

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 07, 2023

 

 

Vapotherm, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-38740

46-2259298

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

100 Domain Drive

 

Exeter, New Hampshire

 

03833

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 603 658-0011

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

VAPO

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On December 11, 2023, Vapotherm, Inc. (the “Company”) announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and its filing of an application to have its common stock quoted on the OTCQX Marketplace (“OTCQX”).

The Board of Directors of the Company approved the voluntary delisting on December 7, 2023 and the Company provided notice of the voluntary delisting to the NYSE on December 11, 2023. The Company intends to file a Form 25 with the Securities and Exchange Commission (the “SEC”) to effect the delisting of its common stock on or about December 21, 2023. It is anticipated that the delisting will become effective on or about December 31, 2023 when the Form 25 takes effect. The Company expects the last day of trading of its common stock on the NYSE will be on or about December 29, 2023. The Company has made an application to have its common stock quoted on OTCQX and expects that the common stock will be quoted on the OTCQX under its current trading symbol “VAPO” on the next trading day after NYSE trading is no longer available, subject to the approval of the OTCQX.

The Company will remain subject to the periodic reporting requirements of the Securities Exchange Act of 1934, as amended, following the delisting of its common stock from the NYSE. Stockholders will not be required to exchange any shares, and the Company expects electronic trading to be available without any material disruption.

Concurrently with the delivery of the notice to the NYSE, the Company issued a press release to announce its intention to voluntarily delist the common stock. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Cautionary Note Regarding Forward Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this report are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “expect,” “will,” “plan,” “anticipate,” “could,” “intend,” “believe,” “estimate,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words, and the use of future dates. Forward-looking statements in this report include, but are not limited to, statements regarding the timing and effect of the Company’s delisting from NYSE and transfer to OTCQX. The forward-looking statements in this report are only predictions and are based largely on the Company’s current expectations and projections about future events and financial trends that it believes may affect its business, financial condition and results of operations. These forward-looking statements speak only as of the date of this report and are subject to a number of known and unknown risks, uncertainties and assumptions, including without limitation, risks associated with the delisting from NYSE, the Company’s ability to successfully transfer to OTCQX, the possibility that the Company’s common stock may be involuntarily delisted from the NYSE prior to the effectiveness of the voluntary delisting, market conditions and the impact of these changes on the trading and price of the Company’s common stock and other risks described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC on February 23, 2023 and in its other subsequent filings with the SEC, including its most recent Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 as filed with the SEC on November 8, 2023. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond the Company’s control, investors should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in the Company’s forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, the Company does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

Number

 

 

Description

99.1

 

Press Release Issued by Vapotherm, Inc. on December 11, 2023

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Vapotherm, Inc.

 

 

 

 

Date:

December 11, 2023

By:

/s/ John Landry

 

 

 

John Landry
Senior Vice President and Chief Financial Officer

 

 EX-99.1 2 vapo-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

img168988987_0.jpg 

 

Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock

 

Application Pending to Transfer Shares to OTCQX

EXETER, N.H.—December 11, 2023 /PRNewswire/ -- Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and its filing of an application to have its common stock quoted on the OTCQX Marketplace (“OTCQX”).

Vapotherm provided notice of the voluntary delisting to the NYSE on December 11, 2023 and intends to timely file a Form 25 with the Securities and Exchange Commission (the “SEC”) to effect the delisting. It is anticipated that the delisting will become effective on or about December 31, 2023. Although the timing of the Company’s decision was driven in part by the determination it could soon fall out of compliance with the NYSE $15 million market capitalization requirement, the Company has been evaluating its listing options for some time and has concluded that, for Vapotherm, the cost of an NYSE listing, and the management attention required to maintain compliance with NYSE listing standards, outweighs the benefits of being listed on that exchange. Eliminating the effort required to maintain compliance with NYSE listing standards will better enable the Company to focus on its customers, its business, and the patients whose lives are enhanced as a result of its work. The Company has made an application to have its common stock quoted on OTCQX and expects that the common stock will be quoted on the OTCQX under its current trading symbol “VAPO” on the next trading day after NYSE trading is no longer available, subject to the approval of the OTCQX. The Company expects that transferring its shares to the OTCQX will enable its investors to hold and trade its shares without interruption.

The Company will remain subject to the periodic reporting requirements of the Securities Exchange Act of 1934, as amended, following the delisting of its common stock from the NYSE. Stockholders will not be required to exchange any shares, and the Company expects electronic trading to be available without any material disruption.

This announcement follows the Company’s previously disclosed receipts of notices from the NYSE that the Company is out of compliance with the NYSE’s continued listing standards. The Company has taken actions to remain in compliance, including a reverse stock split, and has been evaluating its options with respect to its NYSE listing after discussions and deliberations on these matters. Ultimately, the Company’s Board of Directors determined that it is in the best interests of the Company and its stockholders to voluntarily delist the Company’s common stock from the NYSE and move to the OTCQX at this time instead of continuing efforts to satisfy the NYSE continued listing requirements.

About Vapotherm

Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The Company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 4.1 million patients have been treated with the use of Vapotherm high velocity therapy® systems. For more information, visit www.vapotherm.com.

Vapotherm high velocity therapy is mask-free non-invasive respiratory support and is a front-line tool for relieving respiratory distress—including hypercapnia, hypoxemia, and dyspnea. It allows for the fast, safe treatment of undifferentiated respiratory distress with one tool. The HVT 2.0 and Precision Flow systems’ mask-free interface delivers optimally conditioned breathing gases, making it comfortable for patients and reducing the risks and care complexities associated with mask therapies. While being treated, patients can talk, eat, drink and take oral medication.

Website Information

Vapotherm routinely posts important information for investors on the Investor Relations section of its website, http:// investors.vapotherm.com/. Vapotherm intends to use this website as a means of disclosing material, non-public information and for complying with Vapotherm’s disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investor Relations section of Vapotherm’s website, in addition to following Vapotherm’s press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, Vapotherm’s website is not incorporated by reference into, and is not a part of, this document.

Legal Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995, including statements about the delisting of the Company’s common stock and the future quotation of the Company’s common stock on the OTCQX and the timing thereof. In some cases, you can identify forward-looking statements by

 

 

terms such as “expect,” “anticipate,” “continue,” “plan,” “intend,” “will,” or “typically,” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words, and the use of future dates. Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statement. Applicable risks and uncertainties include, but are not limited to risks associated with the delisting of the Company’s common stock from the NYSE, its application to the OTCQX, the timing of such actions and their effect on the trading or price of the Company’s common stock, and the other risks and uncertainties included under the heading “Risk Factors” in Vapotherm’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as filed with the SEC on February 23, 2023, and in its subsequent filings with the SEC, including its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023. The forward-looking statements contained in this press release reflect Vapotherm’s views as of the date hereof, and Vapotherm does not assume and specifically disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.

 

 

SOURCE: Vapotherm, Inc.

Investor Relations Contacts:

John Landry, SVP & CFO, ir@vtherm.com, +1 (603) 658-0011

 

 

 GRAPHIC 3 img168988987_0.jpg GRAPHIC begin 644 img168988987_0.jpg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end EX-101.PRE 4 vapo-20231207_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 5 vapo-20231207.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 vapo-20231207_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Information, Former Legal or Registered Name Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document And Entity Information
Dec. 07, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 07, 2023
Entity Registrant Name Vapotherm, Inc.
Entity Central Index Key 0001253176
Entity Emerging Growth Company false
Entity File Number 001-38740
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 46-2259298
Entity Address, Address Line One 100 Domain Drive
Entity Address, City or Town Exeter
Entity Address, State or Province NH
Entity Address, Postal Zip Code 03833
City Area Code 603
Local Phone Number 658-0011
Entity Information, Former Legal or Registered Name Not Applicable
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol VAPO
Security Exchange Name NYSE
XML 8 vapo-20231207_htm.xml IDEA: XBRL DOCUMENT 0001253176 2023-12-07 2023-12-07 0001253176 false 8-K 2023-12-07 Vapotherm, Inc. DE 001-38740 46-2259298 100 Domain Drive Exeter NH 03833 603 658-0011 Not Applicable false false false false Common Stock, $0.001 par value per share VAPO NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports vapo-20231207.htm vapo-20231207.xsd vapo-20231207_lab.xml vapo-20231207_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "vapo-20231207.htm": { "nsprefix": "vapo", "nsuri": "http://vapotherm.com/20231207", "dts": { "inline": { "local": [ "vapo-20231207.htm" ] }, "schema": { "local": [ "vapo-20231207.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "vapo-20231207_lab.xml" ] }, "presentationLink": { "local": [ "vapo-20231207_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_44206d3f-252b-4ecc-81c2-bc8efd729b2b", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "vapo-20231207.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_44206d3f-252b-4ecc-81c2-bc8efd729b2b", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "vapo-20231207.htm", "first": true, "unique": true } } }, "tag": { "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityInformationFormerLegalOrRegisteredName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationFormerLegalOrRegisteredName", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Information, Former Legal or Registered Name", "documentation": "Former Legal or Registered Name of an entity" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://vapotherm.com/20231207/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0000950170-23-069190-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-069190-xbrl.zip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�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end